RJA
BTAL icon

Raymond James & Associates’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Raymond James & Associates’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$221K Buy
+11,267
New +$224K ﹤0.01% 3582
2023
Q2 		– Sell
-216,006
Closed -$4.41M – 3846
2023
Q1 		$4.41M Buy
216,006
+55,184
+34% +$1.11M ﹤0.01% 1541
2022
Q4 		$3.41M Buy
160,822
+33,232
+26% +$689K ﹤0.01% 1675
2022
Q3 		$2.59M Buy
+127,590
New +$2.54M ﹤0.01% 1806

Other funds holding BTAL

TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Raymond James & Associates's BTAL Position: Q3 2024 in Review

Raymond James & Associates opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024: 11,267 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3582 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in BTAL as recently as Q1 2023.

Raymond James & Associates first reported a position in BTAL in Q3 2022 and has held it in 4 quarters since. The position peaked at $4.41M in Q1 2023. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.

  • Raymond James & Associates held 11,267 shares of AGF US Market Neutral Anti-Beta Fund worth $221K as of Q3 2024.
  • AGF US Market Neutral Anti-Beta Fund was a new Raymond James & Associates position in Q3 2024.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3582 holding.
  • Raymond James & Associates first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and has held it in 4 quarters since.
  • Raymond James & Associates's AGF US Market Neutral Anti-Beta Fund position peaked at $4.41M in Q1 2023.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.